Laboratorios Farmaceuticos Rovi (FRA:41L) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 06, 2026)


FRA:41L Laboratorios Farmaceuticos Rovi SA FRA:41L
93 GF Score
Price €57.90
GF Value €51.89
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Laboratorios Farmaceuticos Rovi Float Percentage Of Total Shares Outstanding?

Laboratorios Farmaceuticos Rovi FRA:41L +0.87% 93 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 06, 2026. GuruFocus rates FRA:41L with a GF Score™ of 93/100 and a GF Value™ of €51.89 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Laboratorios Farmaceuticos Rovi's float shares is 0.00 Mil. Laboratorios Farmaceuticos Rovi's total shares outstanding is 51.15 Mil. Laboratorios Farmaceuticos Rovi's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Laboratorios Farmaceuticos Rovi's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Laboratorios Farmaceuticos Rovi's Institutional Ownership is 16.36%.

FRA:41L
93GF Score
Laboratorios Farmaceuticos Rovi SA FRA:41L
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorios Farmaceuticos Rovi Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Laboratorios Farmaceuticos Rovi's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/51.15
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Laboratorios Farmaceuticos Rovi (FRA:41L) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 06, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Laboratorios Farmaceuticos Rovi and its competitors.
Is Laboratorios Farmaceuticos Rovi's Float Percentage Of Total Shares Outstanding too high?
Laboratorios Farmaceuticos Rovi's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (FRA:41L) is currently considered Modestly Overvalued. The stock's GF Value™ is €51.89, compared to a current price of €57.90 — trading 11.6% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (FRA:41L), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (FRA:41L) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of €57.90 is trading 11.6% above its estimated GF Value™ of €51.89. GuruFocus considers Laboratorios Farmaceuticos Rovi to be Modestly Overvalued.

Key valuation signals for FRA:41L:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €51.89 vs. price of €57.90 (11.6% above fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the FRA:41L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorios Farmaceuticos Rovi Business Description

Address Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
93GF Score

Get the complete analysis for FRA:41L

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.90
Price
€51.89
GF Value